Hartley Lindsey Marie 4

4 · Axogen, Inc. · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 27, 2026

Axogen (AXGN) CFO Hartley Lindsey Marie Receives Award; Shares Withheld

What Happened

Hartley Lindsey Marie, Chief Financial Officer of Axogen, received performance- and time-based equity on Feb 26, 2026. The filing shows 17,453 shares delivered (vested PSUs/RSUs) at $0.00, 6,630 shares withheld to satisfy tax withholding at $31.90 per share (total value withheld = $211,497), and an additional 23,000 restricted stock units/PSUs granted (derivative award) recorded at $0.00.

Key Details

Transaction dates and prices: Feb 26, 2026. Delivered/vested shares recorded at $0.00; 6,630 shares withheld at $31.90/share (withheld value $211,497). New derivative award: 23,000 RSU/PSUs at $0.00.
Type of activity: Awards/grants (A) and tax withholding (F). The withheld shares represent tax remittance, not an open-market sale (per footnote F2).
Vesting/conditions: The 17,453 shares vested upon attainment and certification of performance criteria (footnote F1). Each RSU represents a contingent right to one share (F3). The newly granted RSUs will fully vest Feb 26, 2030 under a schedule: 50% on Feb 26, 2028, then 25% each subsequent year (F4).
Shares owned after transaction: Not specified in the provided filing details.
Timeliness: Report filed Feb 27, 2026 for transactions on Feb 26, 2026 — appears timely (Form 4s are generally due within two business days).

Context

These transactions are primarily equity compensation: performance-based units vested and additional restricted units were granted. The withholding of 6,630 shares was a tax withholding/net settlement; it does not indicate an open-market sale by the insider. Awards and vesting are common executive compensation events and do not by themselves indicate buying or selling sentiment.

Form 4

Period: 2026-02-26

CFO

Transactions

Award
Common Stock
[F1]
2026-02-26+17,453→ 61,906 total
Tax Payment
Common Stock
[F2]
2026-02-26$31.90/sh−6,630$211,497→ 55,276 total
Award
Restricted Stock Units
[F3][F4]
2026-02-26+23,000→ 23,000 total
→ Common Stock (23,000 underlying)

Footnotes (4)

[F1]This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria.
[F2]This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent an open market sale.
[F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
[F4]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.

Signature

/s/ Marc Began, as attorney-in-fact for Lindsey Hartley|2026-02-27

1 file